• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: collagen proportionate area as a prognostic indicator in NAFLD.

作者信息

Ravaioli Federico, Anstee Quentin M

机构信息

Institute of Cellular Medicine, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.

Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.

出版信息

Aliment Pharmacol Ther. 2019 Jun;49(11):1452-1454. doi: 10.1111/apt.15249.

DOI:10.1111/apt.15249
PMID:31074901
Abstract
摘要

相似文献

1
Editorial: collagen proportionate area as a prognostic indicator in NAFLD.
Aliment Pharmacol Ther. 2019 Jun;49(11):1452-1454. doi: 10.1111/apt.15249.
2
Editorial: collagen proportionate area as a prognostic indicator in NAFLD-authors' reply.社论：胶原比例面积作为非酒精性脂肪性肝病的预后指标——作者回复
Aliment Pharmacol Ther. 2019 Jun;49(11):1454-1455. doi: 10.1111/apt.15271.
3
Letter: use of collagen proportionate area to quantify liver fibrosis and predict clinical outcomes in non-alcoholic fatty liver disease.
Aliment Pharmacol Ther. 2019 Aug;50(3):338. doi: 10.1111/apt.15362.
4
Letter: use of collagen proportionate area to quantify liver fibrosis and predict clinical outcomes non-alcoholic fatty liver disease-authors' reply.信函：使用胶原比例面积来量化肝纤维化并预测非酒精性脂肪性肝病的临床结局——作者回复
Aliment Pharmacol Ther. 2019 Aug;50(3):339. doi: 10.1111/apt.15385.
5
Serum immunoreactive collagen IV detected by monoclonal antibodies as a marker of severe fibrosis in patients with non-alcoholic fatty liver disease.通过单克隆抗体检测血清免疫反应性胶原蛋白IV作为非酒精性脂肪性肝病患者严重纤维化的标志物。
J Gastrointestin Liver Dis. 2015 Mar;24(1):61-8. doi: 10.15403/jgld.2014.1121.yad.
6
Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中血液纤维化检测和 FibroScan 肝硬度测量的诊断准确性和预后意义。
J Hepatol. 2016 Sep;65(3):570-8. doi: 10.1016/j.jhep.2016.04.023. Epub 2016 May 2.
7
Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.非肝硬化非酒精性脂肪性肝病（NAFLD）患者肝细胞癌（HCC）的特征
Hepatol Int. 2016 Jul;10(4):632-9. doi: 10.1007/s12072-015-9679-0. Epub 2015 Nov 11.
8
Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance.非酒精性脂肪性肝病中的肝纤维化——具有预后意义的诊断挑战
World J Gastroenterol. 2015 Oct 21;21(39):11077-87. doi: 10.3748/wjg.v21.i39.11077.
9
Non-alcoholic Fatty Liver Disease (NAFLD)--A Review.非酒精性脂肪性肝病（NAFLD）——综述
Mymensingh Med J. 2015 Oct;24(4):873-80.
10
Prognostic value of high sensitivity C-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease.高敏C反应蛋白在非胰岛素依赖型糖尿病合并非酒精性脂肪性肝病患者中的预后价值
Int J Clin Exp Pathol. 2015 Jul 1;8(7):8494-9. eCollection 2015.